Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
125.89
+0.45 (+0.36%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
69
70
Next >
Why Did Veeva Systems Stock Fall 15% in December?
January 04, 2023
Investors were disappointed by Veeva's growth and profit forecasts.
Via
The Motley Fool
Merck Vs. Pfizer: Why Analyst Upgrades One Pharmaceutical Stock, While Downgrading Another
January 04, 2023
The health care sector held up relatively well in a difficult year for stocks in 2022. On Wednesday, one analyst adjusted his coverage of two large cap pharmaceutical stocks heading into what could be...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 04, 2023
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Analyst Ratings for Merck & Co
January 04, 2023
Via
Benzinga
3 Top Stocks of 2022 That Will Shine Again in 2023
January 04, 2023
The S&P 500 had its worst year since 2008. Of the 143 stocks that gained this past year, these three top stocks of 2022 could do it again.
Via
InvestorPlace
7 Monster Stock Market Predictions – The Week Of January 3, 2023 Edition
January 02, 2023
Things should start returning to normal this week, with a ton of economic data and the December FOMC minutes. The data dump doesn’t begin until Wednesday, with the ISM manufacturing report and JOLTS at...
Via
Talk Markets
$100 Invested In Merck & Co 5 Years Ago Would Be Worth This Much Today
December 23, 2022
Via
Benzinga
Merck, Kelun-Biotech Ink Licensing Pact For Seven Cancer Candidates
December 22, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023
January 04, 2023
Via
Benzinga
Meet the 2023 Dogs of the Dow
January 02, 2023
After a tumultuous year, this simple strategy that outperformed sagging markets might be just what you're looking for.
Via
The Motley Fool
The Dow Stock Dogs Performed In 2022
January 01, 2023
With the market's close on Friday investors happily said goodbye to 2022. Very few investment categories generated a positive return in 2022.
Via
Talk Markets
3 Best Dow Dividend Stocks of 2022: Are They Buys for 2023?
January 01, 2023
At least one of these winners from 2022 should keep the momentum going in the new year.
Via
The Motley Fool
Week In Review: Ten Biggest 2022 China Biopharma Deals Worth $21.5 Billion
December 31, 2022
China Biopharma deal activity in 2022 was certainly slower than the previous year, but the ten largest deals, many of them booked in the second half of the year, totaled a decent $21.5 billion by...
Via
Talk Markets
Have $2,000 to Invest? 2 Top Stocks That Could Go Parabolic
December 30, 2022
Stocks with long-term growth potential abound even in the current market.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 29, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Want to Collect a Dividend Every Month Next Year? Buy These 3 High-Yielding Stocks
December 29, 2022
This is a sound strategy that can help add extra cash to your portfolio every month.
Via
The Motley Fool
Why Is Jounce Therapeutics (JNCE) Stock Up 70% Today?
December 28, 2022
Gilead will try to win approval for what is now GS-1811, while Jounce develops other immunotherapy drugs. JNCE stock is soaring.
Via
InvestorPlace
AT&T, Merck And This Leading Payments Processor Stock On CNBC's 'Final Trades'
December 28, 2022
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named Visa Inc. (NYSE: V), which is down just 5% this year, and has high free cash flow yields
Via
Benzinga
The Surprising Investing Strategy That Made Money in a Horrendous 2022
December 27, 2022
This dog-friendly strategy crushed the market -- and no, it wasn't Shiba Inu or Dogecoin.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 27, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
Biopharma stocks were not immune to the broader market downturn seen for much of 2022.
Via
Benzinga
This Stock Just Soared by 20%: Should You Buy Now?
December 26, 2022
It's been an otherwise poor year for this biotech on the stock market.
Via
The Motley Fool
3 Worst Performing Dow Jones Stocks In 2022
December 24, 2022
The Dow Jones Industrial Average also known as the Dow 30 will likely finish 2022 with a negative return.
Via
Talk Markets
The Best And Worst Performing Stocks Of 2022 (Through 12/22)
December 23, 2022
A look at the best and worst performing Russell 1,000 stocks year-to-date on a total return basis.
Via
Talk Markets
Meta Settles Cambridge Analytica Scandal Case, Microsoft Files Rebuttal To FTC's Lawsuit Against Activision Deal, US Winter Storm Snaps Holiday Plans: Today's Top Stories
December 23, 2022
Reuters
Via
Benzinga
Merck COVID Antiviral Does Not Reduce Risk Of Hospitalization, Death Rates In Vaccinated Individuals
December 23, 2022
Via
Benzinga
7 Drug Stocks That Will Soar in 2023
December 22, 2022
These drug stocks to buy look poised to generate huge profits for investors in 2023 and in subsequent years.
Via
InvestorPlace
7 Perfect Presents to Gift Your 2023 Stock Portfolio
December 21, 2022
As we leave 2022 behind, these hot stocks to buy have significant potential and serious catalysts as we move into New Year 2023.
Via
InvestorPlace
Delta and Moderna Share Good News
December 21, 2022
We've also got a look at money-related New Year's resolutions.
Via
The Motley Fool
After Disappointing Phase 2 Data, Merck Drops Eye Disease Related Pact With NGM Biopharm
December 21, 2022
Via
Benzinga
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
69
70
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.